{"pmid":32376546,"pmcid":"PMC7086127","title":"[Laboratory testing techniques for SARS-CoV-2].","text":["[Laboratory testing techniques for SARS-CoV-2].","The ongoing epidemic of caused by the coronavirus SARS-CoV-2 starting in December 2019 poses a serious public health threat globally. The virus is highly infectious and transmitted mainly through droplets and contacts, and is associated with a high risk of pneumonia. A small number of patients may present with acute respiratory distress syndrome with severe respiratory complications, which can lead even to death. The selection of appropriate detection techniques and methods for accurate and rapid identification of pathogens therefore plays a key role in improving the diagnosis and treatment of the patients and containing the outbreak. In this review, the authors gives an overview of the virus laboratory detection technology, including virus isolation and culture, real-time fluorescent PCR, gene sequencing, serological antibody detection, and the gene editing technology based on CRISPR/Cas13 system. These techniques are expected to provide valuable assistance in controlling the epidemic and new ideas for future researches.","Nan Fang Yi Ke Da Xue Xue Bao","Qiu, Feng","Wang, Huijun","Zhang, Zikang","Cao, Longbin","Wang, Chenlong","Wu, Jingbiao","Du, Qingfeng","32376546"],"abstract":["The ongoing epidemic of caused by the coronavirus SARS-CoV-2 starting in December 2019 poses a serious public health threat globally. The virus is highly infectious and transmitted mainly through droplets and contacts, and is associated with a high risk of pneumonia. A small number of patients may present with acute respiratory distress syndrome with severe respiratory complications, which can lead even to death. The selection of appropriate detection techniques and methods for accurate and rapid identification of pathogens therefore plays a key role in improving the diagnosis and treatment of the patients and containing the outbreak. In this review, the authors gives an overview of the virus laboratory detection technology, including virus isolation and culture, real-time fluorescent PCR, gene sequencing, serological antibody detection, and the gene editing technology based on CRISPR/Cas13 system. These techniques are expected to provide valuable assistance in controlling the epidemic and new ideas for future researches."],"journal":"Nan Fang Yi Ke Da Xue Xue Bao","authors":["Qiu, Feng","Wang, Huijun","Zhang, Zikang","Cao, Longbin","Wang, Chenlong","Wu, Jingbiao","Du, Qingfeng"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376546","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.12122/j.issn.1673-4254.2020.02.04","keywords":["covid-19","pcr","sars-cov-2","gene editing"],"topics":["Diagnosis"],"weight":1,"_version_":1666597097457057792,"score":9.490897,"similar":[{"pmid":32401064,"title":"CRISPR-Cas Systems Based Molecular Diagnostic Tool for Infectious Diseases and Emerging 2019 Novel Coronavirus (COVID-19) Pneumonia.","text":["CRISPR-Cas Systems Based Molecular Diagnostic Tool for Infectious Diseases and Emerging 2019 Novel Coronavirus (COVID-19) Pneumonia.","Emerging infectious diseases, the persistent potential for destabilizing pandemics, remain a global threat leading to excessive morbidity and mortality. The current outbreak of pneumonia caused by 2019 novel coronavirus (COVID-19) illustrated difficulties in lack of effective drugs for treatment. Accurate and rapid diagnostic tools are essential for early recognition and treatment of infectious diseases, allowing timely implementation of infection control, improved clinical care and other public health measures to stop the spread of the disease. CRISPR-Cas technology speed up the development of infectious disease diagnostics with high rapid and accurate. In this review, we summarize current advance regarding diverse CRISPR-Cas systems, including CRISPR-Cas9, CRISPR-Cas12 and CRISPR-Cas13, in the development of fast, accurate and portable diagnostic tests and highlight the potential of CRISPR-Cas13 in COVID-19 Pneumonia and other emerging infectious diseases diagnosis.","J Drug Target","Xiang, Xiaohong","Qian, Keli","Zhang, Zhen","Lin, Fengyun","Xie, Yang","Liu, Yang","Yang, Zongfa","32401064"],"abstract":["Emerging infectious diseases, the persistent potential for destabilizing pandemics, remain a global threat leading to excessive morbidity and mortality. The current outbreak of pneumonia caused by 2019 novel coronavirus (COVID-19) illustrated difficulties in lack of effective drugs for treatment. Accurate and rapid diagnostic tools are essential for early recognition and treatment of infectious diseases, allowing timely implementation of infection control, improved clinical care and other public health measures to stop the spread of the disease. CRISPR-Cas technology speed up the development of infectious disease diagnostics with high rapid and accurate. In this review, we summarize current advance regarding diverse CRISPR-Cas systems, including CRISPR-Cas9, CRISPR-Cas12 and CRISPR-Cas13, in the development of fast, accurate and portable diagnostic tests and highlight the potential of CRISPR-Cas13 in COVID-19 Pneumonia and other emerging infectious diseases diagnosis."],"journal":"J Drug Target","authors":["Xiang, Xiaohong","Qian, Keli","Zhang, Zhen","Lin, Fengyun","Xie, Yang","Liu, Yang","Yang, Zongfa"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32401064","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1080/1061186X.2020.1769637","keywords":["covid-19","crispr-cas","diagnostics","infectious diseases"],"locations":["Pneumonia"],"topics":["Diagnosis"],"weight":1,"_version_":1666714494696423424,"score":216.10327},{"pmid":32349121,"title":"Massively multiplexed nucleic acid detection using Cas13.","text":["Massively multiplexed nucleic acid detection using Cas13.","The overwhelming majority of globally circulating pathogens go undetected, undermining patient care and hindering outbreak preparedness and response. To enable routine surveillance and comprehensive diagnostic applications, there is a need for detection technologies that can scale to test many samples(1-3) while simultaneously testing for many pathogens(4-6). Here, we develop Combinatorial Arrayed Reactions for Multiplexed Evaluation of Nucleic acids (CARMEN), a platform for scalable, multiplexed pathogen detection. In the CARMEN platform, nanoliter droplets containing CRISPR-based nucleic acid detection reagents(7) self-organize in a microwell array(8) to pair with droplets of amplified samples, testing each sample against each CRISPR RNA (crRNA) in replicate. The combination of CARMEN and Cas13 detection (CARMEN-Cas13) enables robust testing of >4,500 crRNA-target pairs on a single array. Using CARMEN-Cas13, we developed a multiplexed assay that simultaneously differentiates all 169 human-associated viruses with >/=10 published genome sequences and rapidly incorporated an additional crRNA to detect the causative agent of the 2020 COVID-19 pandemic. CARMEN-Cas13 further enables comprehensive subtyping of influenza A strains and multiplexed identification of dozens of HIV drug-resistance mutations. CARMEN's intrinsic multiplexing and throughput capabilities make it practical to scale, as miniaturization decreases reagent cost per test >300-fold. Scalable, highly-multiplexed CRISPR-based nucleic acid detection shifts diagnostic and surveillance efforts from targeted testing of high-priority samples to comprehensive testing of large sample sets, greatly benefiting patients and public health(9-11).","Nature","Ackerman, Cheri M","Myhrvold, Cameron","Thakku, Sri Gowtham","Freije, Catherine A","Metsky, Hayden C","Yang, David K","Ye, Simon H","Boehm, Chloe K","Kosoko-Thoroddsen, Tinna-Solveig F","Kehe, Jared","Nguyen, Tien G","Carter, Amber","Kulesa, Anthony","Barnes, John R","Dugan, Vivien G","Hung, Deborah T","Blainey, Paul C","Sabeti, Pardis C","32349121"],"abstract":["The overwhelming majority of globally circulating pathogens go undetected, undermining patient care and hindering outbreak preparedness and response. To enable routine surveillance and comprehensive diagnostic applications, there is a need for detection technologies that can scale to test many samples(1-3) while simultaneously testing for many pathogens(4-6). Here, we develop Combinatorial Arrayed Reactions for Multiplexed Evaluation of Nucleic acids (CARMEN), a platform for scalable, multiplexed pathogen detection. In the CARMEN platform, nanoliter droplets containing CRISPR-based nucleic acid detection reagents(7) self-organize in a microwell array(8) to pair with droplets of amplified samples, testing each sample against each CRISPR RNA (crRNA) in replicate. The combination of CARMEN and Cas13 detection (CARMEN-Cas13) enables robust testing of >4,500 crRNA-target pairs on a single array. Using CARMEN-Cas13, we developed a multiplexed assay that simultaneously differentiates all 169 human-associated viruses with >/=10 published genome sequences and rapidly incorporated an additional crRNA to detect the causative agent of the 2020 COVID-19 pandemic. CARMEN-Cas13 further enables comprehensive subtyping of influenza A strains and multiplexed identification of dozens of HIV drug-resistance mutations. CARMEN's intrinsic multiplexing and throughput capabilities make it practical to scale, as miniaturization decreases reagent cost per test >300-fold. Scalable, highly-multiplexed CRISPR-based nucleic acid detection shifts diagnostic and surveillance efforts from targeted testing of high-priority samples to comprehensive testing of large sample sets, greatly benefiting patients and public health(9-11)."],"journal":"Nature","authors":["Ackerman, Cheri M","Myhrvold, Cameron","Thakku, Sri Gowtham","Freije, Catherine A","Metsky, Hayden C","Yang, David K","Ye, Simon H","Boehm, Chloe K","Kosoko-Thoroddsen, Tinna-Solveig F","Kehe, Jared","Nguyen, Tien G","Carter, Amber","Kulesa, Anthony","Barnes, John R","Dugan, Vivien G","Hung, Deborah T","Blainey, Paul C","Sabeti, Pardis C"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32349121","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1038/s41586-020-2279-8","topics":["Diagnosis"],"weight":1,"_version_":1666138495461097472,"score":208.64069},{"pmid":32292623,"pmcid":"PMC7102540","title":"Recent advances and perspectives of nucleic acid detection for coronavirus.","text":["Recent advances and perspectives of nucleic acid detection for coronavirus.","The recent pneumonia outbreak caused by a novel coronavirus (SARS-CoV-2) in Chinais posing a great threat to global public health. Therefore, rapid and a accurate identification of pathogenic viruses plays a vital role in selecting appropriate treatments, saving people's lives and preventing epidemics. It is important to establish a quick standard diagnostic test for the detection of the infectious disease (COVID-19) to prevent subsequent secondary spread. Polymerase chain reaction (PCR) is regarded as a gold standard test for the molecular diagnosis of viral and bacterial infections with high sensitivity and specificity. Isothermal nucleic acid amplification is considered to be a highly promising candidate method due to its fundamental advantage in quick procedure time at constant temperature without thermocycler operation. A variety of improved or new approaches also have been developed. This review summarizes the currently available detection methods for coronavirus nucleic acid. It is anticipated that this will assist researchers and clinicians in developing better techniques for timely and effective detection of coronavirus infection.","J Pharm Anal","Shen, Minzhe","Zhou, Ying","Ye, Jiawei","Abdullah Al-Maskri, Abdu Ahmed","Kang, Yu","Zeng, Su","Cai, Sheng","32292623"],"abstract":["The recent pneumonia outbreak caused by a novel coronavirus (SARS-CoV-2) in Chinais posing a great threat to global public health. Therefore, rapid and a accurate identification of pathogenic viruses plays a vital role in selecting appropriate treatments, saving people's lives and preventing epidemics. It is important to establish a quick standard diagnostic test for the detection of the infectious disease (COVID-19) to prevent subsequent secondary spread. Polymerase chain reaction (PCR) is regarded as a gold standard test for the molecular diagnosis of viral and bacterial infections with high sensitivity and specificity. Isothermal nucleic acid amplification is considered to be a highly promising candidate method due to its fundamental advantage in quick procedure time at constant temperature without thermocycler operation. A variety of improved or new approaches also have been developed. This review summarizes the currently available detection methods for coronavirus nucleic acid. It is anticipated that this will assist researchers and clinicians in developing better techniques for timely and effective detection of coronavirus infection."],"journal":"J Pharm Anal","authors":["Shen, Minzhe","Zhou, Ying","Ye, Jiawei","Abdullah Al-Maskri, Abdu Ahmed","Kang, Yu","Zeng, Su","Cai, Sheng"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292623","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jpha.2020.02.010","keywords":["coronavirus","isothermal nucleic acid amplification-based methods","microarray-based methods","nucleic acid detection","pcr-based methods"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494433492992,"score":203.66203},{"pmid":32466458,"title":"Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.","text":["Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.","The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.","Viruses","Younes, Nadin","Al-Sadeq, Duaa W","Al-Jighefee, Hadeel","Younes, Salma","Al-Jamal, Ola","Daas, Hanin I","Yassine, Hadi M","Nasrallah, Gheyath K","32466458"],"abstract":["The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19."],"journal":"Viruses","authors":["Younes, Nadin","Al-Sadeq, Duaa W","Al-Jighefee, Hadeel","Younes, Salma","Al-Jamal, Ola","Daas, Hanin I","Yassine, Hadi M","Nasrallah, Gheyath K"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32466458","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3390/v12060582","keywords":["covid-19","sars-cov-2","diagnostic challenges","molecular testing","serology","viruses"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1668420887292936193,"score":187.78448},{"pmid":32451808,"title":"Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review.","text":["Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review.","Coronaviruses (CoVs) are a large family of viruses that are common in many animal species, including camels, cattle, cats and bats. Animal CoVs, such as Middle East respiratory syndrome-CoV, severe acute respiratory syndrome (SARS)-CoV, and the new virus named SARS-CoV-2, rarely infect and spread among humans. On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organisation declared the outbreak of the resulting disease from this new CoV called 'COVID-19', as a 'public health emergency of international concern'. This global pandemic has affected almost the whole planet and caused the death of more than 315,131 patients as of the date of this article. In this context, publishers, journals and researchers are urged to research different domains and stop the spread of this deadly virus. The increasing interest in developing artificial intelligence (AI) applications has addressed several medical problems. However, such applications remain insufficient given the high potential threat posed by this virus to global public health. This systematic review addresses automated AI applications based on data mining and machine learning (ML) algorithms for detecting and diagnosing COVID-19. We aimed to obtain an overview of this critical virus, address the limitations of utilising data mining and ML algorithms, and provide the health sector with the benefits of this technique. We used five databases, namely, IEEE Xplore, Web of Science, PubMed, ScienceDirect and Scopus and performed three sequences of search queries between 2010 and 2020. Accurate exclusion criteria and selection strategy were applied to screen the obtained 1305 articles. Only eight articles were fully evaluated and included in this review, and this number only emphasised the insufficiency of research in this important area. After analysing all included studies, the results were distributed following the year of publication and the commonly used data mining and ML algorithms. The results found in all papers were discussed to find the gaps in all reviewed papers. Characteristics, such as motivations, challenges, limitations, recommendations, case studies, and features and classes used, were analysed in detail. This study reviewed the state-of-the-art techniques for CoV prediction algorithms based on data mining and ML assessment. The reliability and acceptability of extracted information and datasets from implemented technologies in the literature were considered. Findings showed that researchers must proceed with insights they gain, focus on identifying solutions for CoV problems, and introduce new improvements. The growing emphasis on data mining and ML techniques in medical fields can provide the right environment for change and improvement.","J Med Syst","Albahri, A S","Hamid, Rula A","Alwan, Jwan K","Al-Qays, Z T","Zaidan, A A","Zaidan, B B","Albahri, A O S","AlAmoodi, A H","Khlaf, Jamal Mawlood","Almahdi, E M","Thabet, Eman","Hadi, Suha M","Mohammed, K I","Alsalem, M A","Al-Obaidi, Jameel R","Madhloom, H T","32451808"],"abstract":["Coronaviruses (CoVs) are a large family of viruses that are common in many animal species, including camels, cattle, cats and bats. Animal CoVs, such as Middle East respiratory syndrome-CoV, severe acute respiratory syndrome (SARS)-CoV, and the new virus named SARS-CoV-2, rarely infect and spread among humans. On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organisation declared the outbreak of the resulting disease from this new CoV called 'COVID-19', as a 'public health emergency of international concern'. This global pandemic has affected almost the whole planet and caused the death of more than 315,131 patients as of the date of this article. In this context, publishers, journals and researchers are urged to research different domains and stop the spread of this deadly virus. The increasing interest in developing artificial intelligence (AI) applications has addressed several medical problems. However, such applications remain insufficient given the high potential threat posed by this virus to global public health. This systematic review addresses automated AI applications based on data mining and machine learning (ML) algorithms for detecting and diagnosing COVID-19. We aimed to obtain an overview of this critical virus, address the limitations of utilising data mining and ML algorithms, and provide the health sector with the benefits of this technique. We used five databases, namely, IEEE Xplore, Web of Science, PubMed, ScienceDirect and Scopus and performed three sequences of search queries between 2010 and 2020. Accurate exclusion criteria and selection strategy were applied to screen the obtained 1305 articles. Only eight articles were fully evaluated and included in this review, and this number only emphasised the insufficiency of research in this important area. After analysing all included studies, the results were distributed following the year of publication and the commonly used data mining and ML algorithms. The results found in all papers were discussed to find the gaps in all reviewed papers. Characteristics, such as motivations, challenges, limitations, recommendations, case studies, and features and classes used, were analysed in detail. This study reviewed the state-of-the-art techniques for CoV prediction algorithms based on data mining and ML assessment. The reliability and acceptability of extracted information and datasets from implemented technologies in the literature were considered. Findings showed that researchers must proceed with insights they gain, focus on identifying solutions for CoV problems, and introduce new improvements. The growing emphasis on data mining and ML techniques in medical fields can provide the right environment for change and improvement."],"journal":"J Med Syst","authors":["Albahri, A S","Hamid, Rula A","Alwan, Jwan K","Al-Qays, Z T","Zaidan, A A","Zaidan, B B","Albahri, A O S","AlAmoodi, A H","Khlaf, Jamal Mawlood","Almahdi, E M","Thabet, Eman","Hadi, Suha M","Mohammed, K I","Alsalem, M A","Al-Obaidi, Jameel R","Madhloom, H T"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451808","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s10916-020-01582-x","keywords":["artificial intelligence","biological data mining","covid-19","coronaviruses","mers-cov","machine learning","sars-cov-2"],"topics":["Diagnosis"],"weight":1,"_version_":1667881798426689536,"score":171.50418}]}